Medical affairs teams rely on effective engagement with treating physicians more than ever before. And understanding how physicians respond to interactions with medical affairs is key to the continued evolution of the function as it takes on an increasingly strategic role.
In a recent study, US-based infectious disease specialists were asked to rate their experience of medical affairs teams in respect of 12 HIV therapies (see Table 1).
Table 1: Products
Physicians were asked to rank overall quality of interactions with medical affairs teams at the product level. Responses indicate that overall, physicians are moderately satisfied with medical affairs engagement, although the results do show a clear leader, with the Genvoya medical affairs team several ranking points ahead of the field. And the battle for second place is a close one, with three competing brands vying for the position.
Measuring the impact of medical affairs activities and performance is of vital importance for understanding what medical affairs is doing right and where improvement is needed.
Click here to discuss this research with a FirstWord consultant.
FirstWord conducts similar research in over 15 competitive disease areas. Contact us to learn more.
To read more Sponsored Story articles, click here.